Skip to main content
. Author manuscript; available in PMC: 2013 Apr 11.
Published in final edited form as: J Neurol Neurosurg Psychiatry. 2012 Jan 30;83(4):424–429. doi: 10.1136/jnnp-2011-301413

Table 1.

Summary of pathologic findings

Variable Summary (N=762)
LB count
Middle frontal (>0) 221 (29%)
  Counts in those with >0 2 (1, 1, 5, 26)
Superior temporal (>0) 262 (34%)
  Counts in those with >0 6 (1, 3, 12, 51)
Inferior parietal (>0) 194 (25%)
  Counts in those with >0 2 (1, 1, 4, 22)
Cingulate gyrus (>0) 256 (34%)
  Counts in those with >0 7 (1, 3, 13, 45)

LBD score
0 (no LBs) 437 (57%)
1 (amygdala predominant) 68 (9%)
2 (brainstem predominant) 6 (1%)
3 (limbic) 94 (12%)
4 (diffuse cortical) 157 (21%)

NFT count
Middle frontal 2 (0, 0, 7, 46)
Superior temporal 5 (0, 1, 12, 47)
Inferior parietal 3 (0, 0, 10, 60)
Hippocampal CA1 8 (0, 2, 15, 55)

Braak NFT stage
Overall 5 (0, 4, 6, 6)
0–II 96 (13%)
III–IV 157 (21%)
V–VI 507 (67%)

SP count
Middle frontal (<50) 150 (20%)
  Counts in those with < 50 7 (0, 0, 29, 48)
Superior temporal (<50) 202 (27%)
  Counts in those with < 50 15 (0, 0, 32, 48)
Inferior parietal (<50) 148 (20%)
  Counts in those with < 50 5 (0, 0, 26, 48)
Motor cortex 18 (0, 9, 30, 50)
Visual cortex 26 (0, 13, 45, 50)

Vascular disease 212 (28%)

Brain weight (g) 1080 (440, 960, 1200, 1630)

The sample median (minimum, 25th percentile, 75th percentile, maximum) is given for numerical variables. LB = Lewy body, NFT = neurofibrillary tangle, SP = senile plaque. Information was unavailable for the following variables: LB count (MF: N=2, ST: N=1, IP: N=3, CG: N=7), NFT count (ST: N=1, IP: N=3, CA1: N=6), Braak NFT stage (N=2), SP count (ST: N=2, IP: N=4, MTR: N=42, VC: N=13), and brain weight (N=25).